A detailed history of State Street Corp transactions in X Biotech Inc. stock. As of the latest transaction made, State Street Corp holds 224,595 shares of XBIT stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
224,595
Previous 202,843 10.72%
Holding current value
$1.51 Million
Previous $1.04 Million 66.6%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.55 - $7.95 $120,723 - $172,928
21,752 Added 10.72%
224,595 $1.74 Million
Q2 2024

Aug 14, 2024

BUY
$4.54 - $9.89 $664,279 - $1.45 Million
146,317 Added 258.85%
202,843 $1.04 Million
Q2 2023

Aug 14, 2023

SELL
$3.06 - $6.38 $2,353 - $4,906
-769 Reduced 1.34%
56,526 $335,000
Q3 2022

Nov 15, 2022

SELL
$3.58 - $5.88 $1,514 - $2,487
-423 Reduced 0.73%
57,295 $207,000
Q2 2022

Aug 15, 2022

SELL
$5.13 - $9.2 $1.37 Million - $2.45 Million
-266,252 Reduced 82.18%
57,718 $325,000
Q1 2022

May 16, 2022

SELL
$8.64 - $11.71 $992,623 - $1.35 Million
-114,887 Reduced 26.18%
323,970 $2.8 Million
Q4 2021

Feb 14, 2022

BUY
$10.95 - $16.07 $35,773 - $52,500
3,267 Added 0.75%
438,857 $4.88 Million
Q3 2021

Nov 15, 2021

BUY
$12.95 - $18.24 $347,526 - $489,488
26,836 Added 6.57%
435,590 $5.64 Million
Q2 2021

Aug 16, 2021

BUY
$15.83 - $17.84 $370,643 - $417,705
23,414 Added 6.08%
408,754 $6.77 Million
Q1 2021

May 17, 2021

BUY
$15.92 - $20.3 $1.76 Million - $2.24 Million
110,430 Added 40.17%
385,340 $6.62 Million
Q4 2020

Feb 16, 2021

BUY
$15.65 - $19.92 $42,724 - $54,381
2,730 Added 1.0%
274,910 $4.3 Million
Q3 2020

Nov 10, 2020

SELL
$13.97 - $21.16 $42,608 - $64,538
-3,050 Reduced 1.11%
272,180 $5.2 Million
Q2 2020

Aug 14, 2020

BUY
$10.39 - $16.07 $91,026 - $140,789
8,761 Added 3.29%
275,230 $3.77 Million
Q1 2020

May 11, 2020

BUY
$8.89 - $24.94 $2.37 Million - $6.65 Million
266,469 New
266,469 $2.83 Million

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $205M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.